发明名称 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
摘要 The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.
申请公布号 US8822511(B2) 申请公布日期 2014.09.02
申请号 US201314033117 申请日期 2013.09.20
申请人 Incyte Corporation 发明人 Combs Andrew P.;Yue Eddy W.;Sparks Richard B.;Zhu Wenyu
分类号 A61K31/4245;C07D413/12;C07D271/08 主分类号 A61K31/4245
代理机构 Fish & Richardson P.C. 代理人 Fish & Richardson P.C.
主权项 1. A method of treating melanoma in a patient, comprising administering to said patient a therapeutically effective amount of a compound selected from compounds of Formula I and compounds of Formula F28:or a pharmaceutically acceptable salt thereof, and an antibody selected from an anti-CTLA-4 antibody and an anti-PD-1 antibody; wherein said treating refers to inhibiting melanoma or ameliorating melanoma; wherein: R1 is NH2 or CH3; R2 is Cl, Br, CF3, CH3, or CN; R3 is H or F; R4 is F, Cl, Br, or I; and n is 1 or 2.
地址 Wilmington DE US